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journal homepage: www.j -bgm.comABSTRACTRole of nuclear proteins in
doxorubicin-resistance of human uterine
cancer cellsYi-Ling Lu, Eric Hung, Hsiu-Chuan ChouDepartment of Applied Science, National Hsinchu University of Education, Hsinchu, TaiwanBackground: Uterine sarcoma is a rare cancer that forms in the uterine muscles or in the supporting tissues of the uterine
glands. Doxorubicin (Adriamycin or Doxil) is commonly used in the chemo-treatment of this cancer. While poor prognosis
has been observed in uterine sarcoma, the risk of drug resistance is often promoted by over-treating with doxorubicine over
a 2-year time period. Since as much as 60% of doxorubicin is found in cell nuclei, it is interesting to investigate the rela-
tionship between nuclear proteins and doxorubicin resistance.
Materials and Methods: MES-SA, a common uterine sarcoma cell line, was used as a doxorubicin-sensitive cell line, while
MES-SA-2mM and MES-SA-8mM were established in the lab as the low doxorubicin-resistant and high doxorubicin-resistant cell
lines, respectively. By means of 2D-DIGE, MALDI-TOF and Mascot search engine, differentially expressed proteins were
identified. Subsequently, these identified proteins were validated by using Western blot. Furthermore, the STRING database
was used to select key proteins in the predicted protein-protein networks. Key proteins were then silenced down by RNA
interference (RNAi) to see whether the drug resistance is able to be inhibited.
Results: After MALDI-TOF MS and Mascot search, 23 nuclear proteins differentially expressed in response to the degree of
doxorubicin-resistance. In STRING analysis chart, PARK-7 is shown as the central protein among the functional pathways of
these nuclear proteins. This result was validated by western blotting. PARK-7 was therefore knockdown by siRNA to
investigate its role in the regulation of drug resistance of uterine sarcoma.
Discussion: PARK-7, also called DJ-1, was first found in Parkinson’s disease. Besides, PARK7 is an oncogene which has been
associated with other cancers, including prostate cancer, where it can be stabilized by androgens and antiandrogens. The
androgen receptor (AR) was identified and confirmed as a PARK7 (DJ-1) binding partner. This is the first evidence that PARK7
directly interacts with AR. Importantly, both the subcellular localization of PARK7 and the interaction with AR are regulated
by androgens and antiandrogens. Recent researches also indicated that it can be a marker in non-small cell lung cancer
(NSCLC). In addition, PARK7 was confirmed the connection of PTEN, a tumor suppressor gene in human cancer cell. In these
researches, PARK7 is considered as an antagonist of PTEN function in Drosophila eye. Therefore, PARK-7 is the potential
target for the development of doxorubicin-resistance in human uterine sarcoma. In the future work, cell proliferation by
MTT assay and cell cycle arrest or cell apoptosis by flow cytometry will be used to detect cell viability in this research.2214-0247/$36 Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier Taiwan LLC. All rights reserved.
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